Lenalidomide, 10MG, 15MG, 25MG
Ended Awarded Last action
- Contract number
- 36C26125N0760
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $29,430
Award facts
- Contract value 100% obligated
- $29,430.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$6,690 | |
| Original award | $36,120 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,430.43 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide in three strengths (10mg, 15mg, and 25mg). This delivery order, issued without set-aside designation, represents a requirements-based procurement under the broader Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is scheduled for completion by October 25, 2025. Exelan will perform all work at its Boca Raton, Florida facility, where the company specializes in pharmaceutical manufacturing, repackaging, and distribution services for federal healthcare systems.
Exelan Pharmaceuticals has established itself as a critical supplier to the VA system, with an extensive portfolio of single-award Indefinite Delivery Contracts for medications exceeding $400 million in total ceiling value. The company's primary focus includes supplying Lenalidomide across multiple VA networks for oncology and hematologic malignancy treatment protocols, with prior delivery orders ranging substantially higher than this award. As a foreign-owned, for-profit pharmaceutical distributor, Exelan operates exclusively as a prime contractor with no identified subcontractors and maintains active registration in the System for Award Management through July 30, 2026. The company's unrestricted competition across all awarded contracts demonstrates its qualification to serve the federal government's pharmaceutical procurement requirements on a fully open basis.
Quick answers
Who was awarded contract 36C26125N0760?
36C26125N0760 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 25, 2025.
How much is contract 36C26125N0760 worth?
The government has obligated $29,430 on 36C26125N0760.
Is contract 36C26125N0760 an order under another contract?
Yes. 36C26125N0760 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26125N0760 competed?
The extent of competition for 36C26125N0760 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award